Kurs
0,00%
Kurs
0,00%
Open
55,00
High
56,60
Low
55,00
Close
56,00
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Likviditet
2,77 MNOK
Likviditet
2,77 MNOK
Rel. mcap
0,31%
Antal aktier
49 444
Likviditet under dagen för detta pressmeddelande
Kalender
Est. tid* | ||
2025-10-23 | 08:00 | Kvartalsrapport 2025-Q3 |
2025-07-10 | 08:00 | Kvartalsrapport 2025-Q2 |
2025-05-07 | - | X-dag ordinarie utdelning GENT 0.40 NOK |
2025-05-07 | - | Kvartalsrapport 2025-Q1 |
2025-05-06 | - | Årsstämma |
2025-02-12 | - | Bokslutskommuniké 2024 |
2024-10-31 | - | Kvartalsrapport 2024-Q3 |
2024-08-29 | - | Kvartalsrapport 2024-Q2 |
2024-04-30 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
2024-04-30 | - | Kvartalsrapport 2024-Q1 |
2024-04-29 | - | Årsstämma |
2024-02-09 | - | Bokslutskommuniké 2023 |
2023-10-26 | - | Kvartalsrapport 2023-Q3 |
2023-08-24 | - | Kvartalsrapport 2023-Q2 |
2023-05-05 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
2023-05-05 | - | Kvartalsrapport 2023-Q1 |
2023-05-04 | - | Årsstämma |
2023-02-16 | - | Bokslutskommuniké 2022 |
2022-10-27 | - | Kvartalsrapport 2022-Q3 |
2022-08-25 | - | Kvartalsrapport 2022-Q2 |
2022-05-19 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
2022-05-18 | - | Årsstämma |
2022-04-28 | - | Kvartalsrapport 2022-Q1 |
2022-02-17 | - | Bokslutskommuniké 2021 |
2021-10-21 | - | Kvartalsrapport 2021-Q3 |
2021-08-25 | - | Kvartalsrapport 2021-Q2 |
2021-05-05 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
2021-05-04 | - | Årsstämma |
2021-04-16 | - | Kvartalsrapport 2021-Q1 |
2021-02-11 | - | Bokslutskommuniké 2020 |
2020-10-29 | - | Kvartalsrapport 2020-Q3 |
2020-08-21 | - | Kvartalsrapport 2020-Q2 |
2020-05-15 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
2020-05-14 | - | Årsstämma |
2020-04-24 | - | Kvartalsrapport 2020-Q1 |
2020-02-14 | - | Bokslutskommuniké 2019 |
2019-11-21 | - | Extra Bolagsstämma 2019 |
2019-05-10 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
2018-07-13 | - | Extra Bolagsstämma 2018 |
2018-06-13 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
2018-02-27 | - | Bokslutskommuniké 2017 |
2017-06-06 | - | Årsstämma |
Beskrivning
Land | Norge |
---|---|
Lista | Oslo Bors |
Sektor | Hälsovård |
Industri | Bioteknik |
2025-05-22 10:47:47
Oslo, 22 May 2025, Notification of trade
Carpe Diem Afseth AS ("Carpe Diem") has today, 22 May 2025, acquired 10,000
shares in Gentian Diagnostics ASA ("Gentian"). Following the acquisition, Carpe
Diem owns 772,816 shares in Gentian which represents a total of 5.01% of
Gentian's issued shares and
voting rights (based on 15,422,350 shares issued by Gentian). Carpe Diem is 100%
owned by John Afseth who has no formal role in Gentian.
This disclosure is made pursuant to section 4-2 of the Norwegian Securities
Trading Act and is subject to the disclosure requirement pursuant to section
5-12 of the Norwegian Securities Trading Act.